Index by author

April 01, 2001; Volume 28,Issue 4

A

  1. Aceves-Avila, F J

    1. The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;

  2. Acquista, C A

    1. Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;

  3. Adamopoulos, G K

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  4. Agarwal, V

    1. Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;

  5. Aggarwal, A

    1. Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;

  6. Allevi, E

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  7. Alvarez-Blanco, M J

    1. Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.
      J de Dios García-Díaz and M J Alvarez-Blanco
      The Journal of Rheumatology April 1 2001, 28 (4) 925-926;

  8. Arnold, S

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  9. Asherson, R A

    1. The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;

  10. Athreya, B H

    1. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;

B

  1. Badley, E

    1. Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;

  2. Bernareggi, M

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  3. Boers, M

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
    2. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    3. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    4. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    5. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
    6. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  4. Boki, K A

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  5. Bonfá, E

    1. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
      E F Borba and E Bonfá
      The Journal of Rheumatology April 1 2001, 28 (4) 780-785;

  6. Boonen, A

    1. Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  7. Borba, E F

    1. Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.
      E F Borba and E Bonfá
      The Journal of Rheumatology April 1 2001, 28 (4) 780-785;

  8. Bottasso, B

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  9. Bresnihan, B

    1. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

  10. Brooks, C D

    1. Sulfasalazine for the management of juvenile rheumatoid arthritis.
      C D Brooks
      The Journal of Rheumatology April 1 2001, 28 (4) 845-853;

  11. Bruynesteyn, K

    1. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    2. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  12. Buchanan, W W

    1. Rheumatoid arthritis: beyond the lymphocyte.
      W W Buchanan and W F Kean
      The Journal of Rheumatology April 1 2001, 28 (4) 691-693;

  13. Buratti, S

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  14. Burkhardt, D

    1. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

C

  1. Cantatore, F P

    1. Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;

  2. Cantini, F

    1. Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;

  3. Caria, M C

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  4. Casado, E

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  5. Catena, L

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  6. Chang, M

    1. DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;

  7. Chaudhry-Ahluwalia, V

    1. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

  8. Clark, B J

    1. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;

  9. Clark-Soloninka, C A

    1. In vitro thrombin generation.
      C A Clark-Soloninka and C A Laskin
      The Journal of Rheumatology April 1 2001, 28 (4) 919-920;

  10. Clotet, B

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  11. Cook, R J

    1. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

  12. Corrado, A

    1. Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;

  13. Coyle, D

    1. Treatment related mortality versus quality of life--a balancing act.
      R J McKendry and D Coyle
      The Journal of Rheumatology April 1 2001, 28 (4) 688-690;

  14. Cugno, M

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

D

  1. de Dios García-Díaz, J

    1. Glucocorticoids but not NSAID abort attacks in hyper-IgD and periodic fever syndrome.
      J de Dios García-Díaz and M J Alvarez-Blanco
      The Journal of Rheumatology April 1 2001, 28 (4) 925-926;

  2. de Jong, Z

    1. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

  3. Di Battista, J A

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;

  4. Doran, M

    1. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

E

  1. Edmonds, J

    1. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    2. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  2. Emery, P

    1. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  3. Erben, R G

    1. Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;

F

  1. Fernandes, J C

    1. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  2. Fitzgerald, O

    1. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

  3. Fraga, A

    1. The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;

  4. Fry, J

    1. Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;

G

  1. Gardinali, M

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  2. Geirsson, A J

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  3. Ghosh, P

    1. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

  4. Gladman, D D

    1. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

  5. Glazier, R

    1. Arthritis and rheumatism are neglected health priorities: a bibliometric study.
      R Glazier, J Fry and E Badley
      The Journal of Rheumatology April 1 2001, 28 (4) 706-711;

  6. Goldman, J A

    1. Fibromyalgia and hypermobility.
      J A Goldman
      The Journal of Rheumatology April 1 2001, 28 (4) 920-921;

  7. Guevara, J P

    1. Point prevalence of cardiac abnormalities in children with systemic lupus erythematosus.
      J P Guevara, B J Clark and B H Athreya
      The Journal of Rheumatology April 1 2001, 28 (4) 854-859;

  8. Gumanovskaya, M L

    1. Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

H

  1. Haas-Smith, S A

    1. Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells.
      C Ritchlin and S A Haas-Smith
      The Journal of Rheumatology April 1 2001, 28 (4) 698-705;

  2. Hall, C

    1. Unusual presentation of polyarteritis nodosa.
      C Hall and A B Mongey
      The Journal of Rheumatology April 1 2001, 28 (4) 871-873;

  3. Hallet, D C

    1. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

  4. Hamada, J

    1. Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

  5. Häntzschel, H

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  6. Hasty, K A

    1. Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

  7. Hayashi, Y

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  8. Hazes, J M

    1. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

  9. He, Y

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;

  10. Heufelder, A E

    1. Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;

  11. Hofbauer, L C

    1. Osteoprotegerin, RANK, and RANK ligand: the good, the bad, and the ugly in rheumatoid arthritis.
      L C Hofbauer, A E Heufelder and R G Erben
      The Journal of Rheumatology April 1 2001, 28 (4) 685-687;

  12. Hoffman, R W

    1. DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;

  13. Holgado, S

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  14. Hoshino, T

    1. Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

  15. Houben, H

    1. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;

  16. Hunder, G G

    1. Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;

  17. Husby, G

    1. Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;

  18. Hwa, S Y

    1. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

I

  1. Iannone, F

    1. Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;

  2. Imanaka, H

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  3. Ioannidis, J P

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

J

  1. Johnson, K

    1. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  2. Johnson, K R

    1. Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    2. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;

  3. Jolicoeur, F C

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;

  4. Jovanovic, D V

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;

  5. Julkunen, H

    1. Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;

K

  1. Kaltenhäuser, S

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  2. Kean, W F

    1. Rheumatoid arthritis: beyond the lymphocyte.
      W W Buchanan and W F Kean
      The Journal of Rheumatology April 1 2001, 28 (4) 691-693;

  3. Kere, J

    1. Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;

  4. Kesavan, R B

    1. Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;

  5. Khan, W

    1. Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;

  6. Kievit, J

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;

  7. Kirwan, J

    1. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  8. Kirwan, J R

    1. Links between radiological change, disability, and pathology in rheumatoid arthritis.
      J R Kirwan
      The Journal of Rheumatology April 1 2001, 28 (4) 881-886;

  9. Koldingsnes, W

    1. Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;
    2. Renal granuloma and glomerulonephritis in Wegener's granulomatosis.
      H Nossent and W Koldingsnes
      The Journal of Rheumatology April 1 2001, 28 (4) 878-879;

  10. Koskenmies, S

    1. Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;

  11. Kunavarapu, C

    1. Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;

L

  1. Lajeunesse, D

    1. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  2. Landewé, R B

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;

  3. Lapadula, G

    1. Extracellular matrix interactions with osteoblasts in osteoarthritis. A preliminary report.
      F P Cantatore, C A Acquista, A Corrado, F Iannone and G Lapadula
      The Journal of Rheumatology April 1 2001, 28 (4) 922-924;

  4. Laskin, C A

    1. In vitro thrombin generation.
      C A Clark-Soloninka and C A Laskin
      The Journal of Rheumatology April 1 2001, 28 (4) 919-920;

  5. Lassere, M

    1. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    3. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  6. Lassere, M N

    1. Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    2. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    3. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  7. Lau, C S

    1. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;

  8. Little, C

    1. The effects of orally administered diacerein on cartilage and subchondral bone in an ovine model of osteoarthritis.
      S Y Hwa, D Burkhardt, C Little and P Ghosh
      The Journal of Rheumatology April 1 2001, 28 (4) 825-834;

  9. Loeffler, M

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  10. Loizou, S

    1. The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;

  11. Lorenzo, J C

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  12. Lubahn, D B

    1. DNA microsatellite markers for estrogen receptor-beta are not associated with systemic lupus erythematosus.
      M Chang, D B Lubahn and R W Hoffman
      The Journal of Rheumatology April 1 2001, 28 (4) 924-925;

M

  1. Maeno, N

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  2. Malattia, C

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  3. Manfredsdottir, V

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  4. Maragkoudakis, P V

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  5. Martel-Pelletier, J

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  6. Martini, A

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  7. McKendry, R J

    1. Treatment related mortality versus quality of life--a balancing act.
      R J McKendry and D Coyle
      The Journal of Rheumatology April 1 2001, 28 (4) 688-690;

  8. Medina, F

    1. The antiquity of rheumatoid arthritis: a reappraisal.
      F J Aceves-Avila, F Medina and A Fraga
      The Journal of Rheumatology April 1 2001, 28 (4) 751-757;

  9. Mellgren, S I

    1. Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;

  10. Mineau, F

    1. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  11. Misra, R

    1. Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;

  12. Miyata, K

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  13. Mohan, S S

    1. Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;

  14. Mok, C C

    1. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;

  15. Molenaar, E

    1. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  16. Mongey, A B

    1. Unusual presentation of polyarteritis nodosa.
      C Hall and A B Mongey
      The Journal of Rheumatology April 1 2001, 28 (4) 871-873;

  17. Montani, N

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  18. Moutsopoulos, H M

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  19. Munneke, M

    1. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

N

  1. Nityanand, S

    1. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;

  2. Nossent, H

    1. Renal granuloma and glomerulonephritis in Wegener's granulomatosis.
      H Nossent and W Koldingsnes
      The Journal of Rheumatology April 1 2001, 28 (4) 878-879;

O

  1. Oda, H

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  2. Olivé, A

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  3. Olivieri, I

    1. Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;

  4. Omdal, R

    1. Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;

  5. Ono, W

    1. Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

P

  1. Pal, L

    1. Primary patellar T cell lymphoma: an unusual cause of monoarthritis.
      V Agarwal, L Pal, A Aggarwal and R Misra
      The Journal of Rheumatology April 1 2001, 28 (4) 876-877;

  2. Paulus, H

    1. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;

  3. Pelletier, J P

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  4. Peloso, P

    1. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;

  5. Perez-Andres, R

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  6. Petrou, D

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  7. Pevil-Ulysee, M

    1. Systemic lupus erythematosus presenting as "one-and-a-half syndrome".
      C Kunavarapu, R B Kesavan, M Pevil-Ulysee and S S Mohan
      The Journal of Rheumatology April 1 2001, 28 (4) 874-875;

  8. Pozzi, M R

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

R

  1. Ravelli, A

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  2. Reboul, P

    1. Modulation of TIMP-1 synthesis by antiinflammatory cytokines and prostaglandin E2 in interleukin 17 stimulated human monocytes/macrophages.
      D V Jovanovic, J A Di Battista, J Martel-Pelletier, P Reboul, Y He, F C Jolicoeur and J P Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 712-718;
    2. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  3. Ritchlin, C

    1. Expression of interleukin 10 mRNA and protein by synovial fibroblastoid cells.
      C Ritchlin and S A Haas-Smith
      The Journal of Rheumatology April 1 2001, 28 (4) 698-705;

  4. Romeu, J

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

S

  1. Sabouret, P

    1. Diacerein reduces the excess synthesis of bone remodeling factors by human osteoblast cells from osteoarthritic subchondral bone.
      J P Pelletier, D Lajeunesse, P Reboul, F Mineau, J C Fernandes, P Sabouret and J Martel-Pelletier
      The Journal of Rheumatology April 1 2001, 28 (4) 814-824;

  2. Saevarsdottir, S

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  3. Salvarini, C

    1. Magnetic resonance imaging and polymyalgia rheumatica.
      C Salvarini, F Cantini, I Olivieri and G G Hunder
      The Journal of Rheumatology April 1 2001, 28 (4) 918-919;

  4. Samarkos, M

    1. The clinical significance of IgA antiphospholipid antibodies.
      M Samarkos, R A Asherson and S Loizou
      The Journal of Rheumatology April 1 2001, 28 (4) 694-697;

  5. Saotome, K

    1. Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

  6. Saudan, A

    1. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;

  7. Schuster, E

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  8. Segas, J V

    1. How significant is sensorineural hearing loss in primary Sjögren's syndrome? An individually matched case-control study.
      K A Boki, J P Ioannidis, J V Segas, P V Maragkoudakis, D Petrou, G K Adamopoulos and H M Moutsopoulos
      The Journal of Rheumatology April 1 2001, 28 (4) 798-801;

  9. Seidel, W

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  10. Shirazi, I

    1. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;

  11. Shlopov, B V

    1. Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

  12. Sinha, N

    1. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;

  13. Sont, J K

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;

  14. Stabilini, R

    1. Treatment of Raynaud's phenomenon with intravenous prostaglandin E1alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis.
      M Gardinali, M R Pozzi, M Bernareggi, N Montani, E Allevi, L Catena, M Cugno, B Bottasso and R Stabilini
      The Journal of Rheumatology April 1 2001, 28 (4) 786-794;

  15. Strand, V

    1. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    2. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  16. Stuart, J M

    1. Regulation of cartilage collagenase by doxycycline.
      B V Shlopov, J M Stuart, M L Gumanovskaya and K A Hasty
      The Journal of Rheumatology April 1 2001, 28 (4) 835-842;

T

  1. Takei, S

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  2. Talip, F

    1. Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;

  3. Tamai, K

    1. Analysis of calcium deposits in calcific periarthritis.
      J Hamada, W Ono, K Tamai, K Saotome and T Hoshino
      The Journal of Rheumatology April 1 2001, 28 (4) 809-813;

  4. Temporini, F

    1. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
      A Ravelli, M C Caria, S Buratti, C Malattia, F Temporini and A Martini
      The Journal of Rheumatology April 1 2001, 28 (4) 865-867;

  5. Tena, X

    1. Musculoskeletal manifestations in patients positive for human immunodeficiency virus: correlation with CD4 count.
      E Casado, A Olivé, S Holgado, R Perez-Andres, J Romeu, J C Lorenzo, B Clotet and X Tena
      The Journal of Rheumatology April 1 2001, 28 (4) 802-804;

  6. Tijhuis, G J

    1. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

  7. Tishler, M

    1. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;

  8. Tripathy, N K

    1. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;

  9. Tröltzsch, M

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

U

  1. Upadhyaya, S

    1. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis.
      N K Tripathy, S Upadhyaya, N Sinha and S Nityanand
      The Journal of Rheumatology April 1 2001, 28 (4) 805-808;

  2. Urowitz, M B

    1. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus.
      D D Gladman, M B Urowitz, V Chaudhry-Ahluwalia, D C Hallet and R J Cook
      The Journal of Rheumatology April 1 2001, 28 (4) 761-765;

V

  1. Valdimarsson, H

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  2. van der Heijde, D

    1. Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.
      V Strand, M Lassere, D van der Heijde, K Johnson and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 887-889;
    3. Foundations of the minimal clinically important difference for imaging.
      M N Lassere, D van der Heijde and K R Johnson
      The Journal of Rheumatology April 1 2001, 28 (4) 890-891;
    4. Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
      M N Lassere, D van der Heijde, K R Johnson, M Boers and J Edmonds
      The Journal of Rheumatology April 1 2001, 28 (4) 892-903;
    5. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;
    6. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;
    7. Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
      D van der Heijde, M Lassere, J Edmonds, J Kirwan, V Strand and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 914-917;

  3. van der Linden, S

    1. Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
      A Boonen, D van der Heijde and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 843-844;
    2. Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
      K Bruynesteyn, D van der Heijde, M Boers, M Lassere, A Boonen, J Edmonds, H Houben, H Paulus, P Peloso, A Saudan and S van der Linden
      The Journal of Rheumatology April 1 2001, 28 (4) 904-910;

  4. van Laar, J M

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;

  5. Verburg, R J

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;

  6. Verhoeven, A

    1. Robustness and generalizability of smallest detectable difference in radiological progression.
      M N Lassere, D van der Heijde, K Johnson, K Bruynesteyn, E Molenaar, A Boonen, A Verhoeven, P Emery and M Boers
      The Journal of Rheumatology April 1 2001, 28 (4) 911-913;

  7. Vikingsdottir, T

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  8. Vikingsson, A

    1. Low mannose binding lectin predicts poor prognosis in patients with early rheumatoid arthritis. A prospective study.
      S Saevarsdottir, T Vikingsdottir, A Vikingsson, V Manfredsdottir, A J Geirsson and H Valdimarsson
      The Journal of Rheumatology April 1 2001, 28 (4) 728-734;

  9. Vliet Vlieland, T P

    1. High dose chemotherapy followed by autologous peripheral blood stem cell transplantation or conventional pharmacological treatment for refractory rheumatoid arthritis? A Markov decision analysis.
      R J Verburg, J K Sont, T P Vliet Vlieland, R B Landewé, M Boers, J Kievit and J M van Laar
      The Journal of Rheumatology April 1 2001, 28 (4) 719-727;
    2. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;

W

  1. Wagner, U

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  2. Walker, N

    1. Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;

  3. Wassmuth, R

    1. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity.
      S Kaltenhäuser, U Wagner, E Schuster, R Wassmuth, S Arnold, W Seidel, M Tröltzsch, M Loeffler and H Häntzschel
      The Journal of Rheumatology April 1 2001, 28 (4) 735-744;

  4. Waterloo, K

    1. Somatic and psychological features of headache in systemic lupus erythematosus.
      R Omdal, K Waterloo, W Koldingsnes, G Husby and S I Mellgren
      The Journal of Rheumatology April 1 2001, 28 (4) 772-779;

  5. Widen, E

    1. Familial systemic lupus erythematosus in Finland.
      S Koskenmies, E Widen, J Kere and H Julkunen
      The Journal of Rheumatology April 1 2001, 28 (4) 758-760;

  6. Wong, R W

    1. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
      C C Mok, C S Lau and R W Wong
      The Journal of Rheumatology April 1 2001, 28 (4) 766-771;

  7. Wordsworth, P

    1. A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.
      M Doran, P Wordsworth, B Bresnihan and O Fitzgerald
      The Journal of Rheumatology April 1 2001, 28 (4) 921-922;

Y

  1. Yanagi, K

    1. Anti-alpha-fodrin antibodies in Sjögren's syndrome in children.
      N Maeno, S Takei, H Imanaka, H Oda, K Yanagi, Y Hayashi and K Miyata
      The Journal of Rheumatology April 1 2001, 28 (4) 860-864;

  2. Yaron, I

    1. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;

  3. Yaron, M

    1. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
      M Tishler, I Yaron, I Shirazi and M Yaron
      The Journal of Rheumatology April 1 2001, 28 (4) 795-797;

Z

  1. Zimmermann, B

    1. Treatment of Felty's syndrome with leflunomide.
      F Talip, N Walker, W Khan and B Zimmermann
      The Journal of Rheumatology April 1 2001, 28 (4) 868-870;

  2. Zwinderman, A H

    1. The value of a continuous ambulatory activity monitor to quantify the amount and intensity of daily activity in patients with rheumatoid arthritis.
      M Munneke, Z de Jong, A H Zwinderman, G J Tijhuis, J M Hazes and T P Vliet Vlieland
      The Journal of Rheumatology April 1 2001, 28 (4) 745-750;
Back to top

In this issue